National Hepatitis Elimination Profiles
On World Hepatitis Day in 2019, the Coalition for Global Hepatitis Elimination announced the launch of an initiative to develop National Hepatitis Elimination Profiles for 30 high-burden countries. Developed in collaboration with local stakeholders, the profiles comprehensively assess the status of hepatitis elimination and will be a critical resource for country and global program planning, advocacy, and resource mobilization efforts.
In 2020, The Coalition for Global Hepatitis Elimination developed data dashboards for over 190 countries. The dashboard provide data available globally to monitor vaccination coverage, access to affordable therapies and progress towards hepatitis elimination goals. Working with local partners, the National Hepatitis Elimination Profiles build on the dashboards by collecting additional data available locally and translating the data into advocacy tools for policy development, resource mobilization, and greater commitments to the 2030 goals for hepatitis elimination.
1. Bring together key data to assess status of hepatitis elimination efforts:
- Hepatitis burden
- Implementation of hepatitis prevention, testing and treatment services
- Policy development
- Health equity for key populations
2. Assess progress toward program targets and health outcome goals
3. Highlight achievements, challenges, and feasible next steps
The profiles are also meant to be dynamic and will continue to be updated as new information is shared.
Find out more:
Funding for this N-HEP was provided by Gilead Sciences. The Coalition for Global Hepatitis Elimination retained final control over the content.
To be alerted when new National Hepatitis Elimination Profiles are posted, sign-up for the Coalition newsletter here or email the Coalition at globalhep [at] taskforce.org.
The Coalition thanks Professor Dr. Mohammad Ali of the National Liver Foundation of Bangladesh, Dr. Md Ismail Gazi of Sheikh Russel National Gastroliver Institute and Hospital, and Professor Dr. Mamun-Al-Mahtab of Bangabandhu Sheikh Mujib Medical University for their review and feedback of this profile.
This profile was developed with input from the Public Health Agency of Canada, CATIE, the Canadian Association for the Study of the Liver, and Action Hepatitis Canada.
This Canada profile was originally developed in 2021 but was updated in March 2023. The version available here is the most recent one. Previous versions are available upon request.
The Coalition thanks China Liver Health, Dr Wei Lai, Dr Cui Fuqiang, Dr Chen Zhongdan, Dr Rao Huiying, Dr Rong Yihui and Liang xiaofeng and the Disease Control and Prevention Institute of Jinan University team for their review and feedback.
Download the profile (English)
Download the profile (Mandarin Chinese)
The Coalition thanks the Taiwan National Hepatitis Control Program, especially Dr. Jasmine Pwu from the Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, Taiwan, R.O.C., and Prof. Ming-Lung Yu from Kaohsiung Medical University for their review and feedback.
This profile was developed with input from Dr. Imam Waked, Professor Wahid Doss, Professor Gamal Esmat, Professor Manal Hamdy El-Sayed, and Amr Fahmy. The Coalition thanks Professor Sameera Ezzat and Dr. Mohamed Hassany for their review.
This profile was developed with input from Dr. Hailemichael Desalegn and Hanna Aberra from St. Paul’s Millenium Hospital, Dr. Mengistu Erkie from the Ethiopia Gastroenterology Association, and Mr. Wegene Adugna from the Ministry of Health.
The Coalition thanks the Georgia Scientific Committee, Technical Advisory Group, US CDC, Georgian Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs and the National Center for Disease Control and Public Health for their support in development of this profile.
This profile was developed in collaboration with Dr. Atsu Seake-Kwawu (Ghana Health Service), Dr. Charles Adjei (Ghana Hepatitis Alliance), Dr. Lewis Roberts (Mayo Clinic), Theobald Owusu- Ansah and Richard Laryea (Ghana Hepatitis Foundation), Dr. Kafui Senya (WHO), and Dr. Yvonne Nartey (Cape Coast University).
This profle was developed in collaboration with Prof. Alessandro Zanetti of the University of Milan, Dr. Paolo Bonanni of the University of Florence, Dr. Loreta Kondili of the Istituto Superiore di Sanità in Rome, Dr. Felice Nava of the FeDerSERD (Federazione Italiana degli Operatori dei Dipartimenti e dei Servizi delle Dipendenze), the Italian Society for the Study of the Liver, in particular Prof. Alessio Agehmo, Mr. Ivan Gardini of the EpaC Association, Dr. Antonio Craxi of University of Palermo, Sicily HCV Network, and Prof Massimo Andreoni of the Italian Society of Infectious and Tropical Diseases.
The Coalition thanks Caroline Thomas and Dr. Fatcha Nuraliyah, of the Ministry of Health, for their review and feedback.
The Coalition thanks Prof. Junko Tanaka and Prof. Yasu Tanaka-Kumadai for their review and feedback on the development of the National Hepatitis Elimination Profile
Korea (Republic of)
The Coalition thanks Prof Sang Hoon Ahn, Secretary General of the Korean Association of the Study of the Liver (KASL), Prof Jin Gwack from the Korea Disease Control Agency, and Prof Sook-Hyang Jeong, and Prof Young-Suk Lim at the University of Ulsan College of Medicine for their review and feedback on the development of this profile.
The Coalition thanks Dr. Khin Sanda Aung and Professor Win Win Swe from the Myanmar Ministry of Health, Dr. Khin San Tint and Dr. Thandar Su Naing from CHAI, Dr. Hla Htay from the Burnet Institute, Dr. Khin Pyone Kyi from the Myanmar Liver Foundation, Dr. Win Naing, and Dr. Lynn Thet Su Mon from the WHO Myanmar Office for their review and feedback.
The Coalition thanks the Federal Ministry of Health, Rise Against Hepatitis Global Initiative, especially, Oni Adesuwa, and Care for Social Welfare International (CASWI), especially Ifeanyi Damian, for their review and feedback of this profile.
This profile was developed with input from Dr. Huma Qureshi, the National Viral Hepatitis Focal Point, Dr. Saeed Hamid from Aga Khan University, and Parsa Trust.
The Coalition thanks Dr. Diana Alcantara-Payawal of Fatima University Medical Center and Chris Munoz, Adviser of the Yellow Warriors Society Philippines
This profile was developed in collaboration with Dr. Rui Marinho and the Ministry of Health with input from Rotary Club.
This Portugal profile was originally developed in 2022 but was updated in June 2023. The version available here is the most recent one. Previous versions are available upon request.
The Coalition thanks Andrew Scheibe (TB/HIV Care), Kgomotso Vilakazi-Nhlapo (National Department of Health), Mark Sonderup (University of Cape Town), Nishi Prabdial-Sing (National Institute for Communicable Diseases), and Wendy Spearman (University of Cape Town) for their review and feedback.
The Coalition thanks Prof. Fatou Fall from Hôpital Principal de Dakar, Dr Judicael Tine from Centre Hospitalier National Universitaire de Fann, and Dr. Francoise Roudot-Thoraval for their review and feedback on this profile.
Note this version of the profile is pending final approval.
Download here (English)
If interested in a French N-HEP for Senegal, please email globalhep [at] taskforce.org.
This profile was developed in collaboration with the Alliance for the Elimination of Viral Hepatitis in Spain, especially Javier Garcia-Samaniego, IS Global at the Barcelona Institute for Global Health, especially Jeff Lazarus and Camila Picchio, Maria Buti, and ASSCAT, especially Teresa Casanovas for their review and feedback
This Spain profile was originally developed in 2022 but was updated in June 2023. The version available here is the most recent one. Previous versions are available upon request.
Download here (English), Updated 2023
Download here (Spanish), Published 2022
This profile was developed in collaboration with Dr. Philip Bruggmann, Swiss Hepatitis, and Dr. Francesco Negro for their review and feedback on the development of this National Hepatitis Elimination Profile.
This Switzerland profile was originally developed in 2022 but was updated in June 2023. The version available here is the most recent one. Previous versions are available upon request.
This profile was developed in collaboration with the Ukraine Ministry of Health Public Health Center.
This profile was developed with input from American Association for the Study of the Liver (AASLD), the Hepatitis B Foundation, the National Association of State and Territorial AIDS Directors (NASTAD), the National Viral Hepatitis Roundtable (NVHR), and US CDC.
This US profile was originally developed in 2021 but was updated in March 2023. The version available here is the most recent one. Previous versions are available upon request.